Company Description
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024.
Lifeward Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
Country | Israel |
Founded | 2001 |
IPO Date | Sep 12, 2014 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 108 |
CEO | Lawrence Jasinski |
Contact Details
Address: 3 Hatnufa Street, Floor 6 Yokneam Illit, 2069203 Israel | |
Phone | 972 4 959 0123 |
Website | golifeward.com |
Stock Details
Ticker Symbol | LFWD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001607962 |
ISIN Number | IL0011331076 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Lawrence J. Jasinski BS, MBA | Chief Executive Officer and Director |
Michael A. Lawless | Chief Financial Officer |
Miri Pariente | Vice President of Operations, Regulatory and Quality |
Almog Adar | Vice President of Finance and Chief Accounting Officer |
Jeannine Lynch | Vice President of Market Access and Strategy |
Kathleen O'Donnell | Vice President of Marketing and New Business Development |
Judy Kula | Vice President of Customer Service, Human Resources and Business Affairs |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 25, 2024 | DEF 14A | Other definitive proxy statements |
Nov 15, 2024 | PRE 14A | Other preliminary proxy statements |
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Nov 7, 2024 | 8-K | Current Report |
Sep 16, 2024 | 144 | Filing |
Sep 4, 2024 | 8-K | Current Report |
Aug 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Aug 15, 2024 | 8-K | Current Report |
Aug 14, 2024 | 10-Q | Quarterly Report |